tiprankstipranks
Intra-Cellular 6.85M share Secondary priced at $73.00
PremiumThe FlyIntra-Cellular 6.85M share Secondary priced at $73.00
7d ago
Intra-Cellular Therapies Prices Public Offering of Common Stock
PremiumPress Releases
Intra-Cellular Therapies Prices Public Offering of Common Stock
7d ago
Intra-Cellular price target raised to $91 from $82 at BofA
PremiumThe Fly
Intra-Cellular price target raised to $91 from $82 at BofA
8d ago
Intra-Cellular Advances Depression Treatment with Lumateperone
PremiumCompany AnnouncementsIntra-Cellular Advances Depression Treatment with Lumateperone
9d ago
Intra-Cellular announces Phase 3 results from Study 501
PremiumThe Fly
Intra-Cellular announces Phase 3 results from Study 501
9d ago
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
PremiumPress Releases
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
9d ago
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
PremiumPress ReleasesIntra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
2M ago
Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
PremiumPress Releases
Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
2M ago
JPMorgan biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech analysts to hold an analyst/industry conference call
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100